Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
J.McGrathS
Wegovy is approved for chronic weight management (2021), cardiovascular risk reduction in adults with obesity and CVD (2024), and non-cirrhotic MASH with F2-F3 fibrosis (August 2025)
En adultos sanos y activos, el efecto suele ser poco relevante si no hay un dficit calrico real detrs
*Side effects may occur and include the following: Low blood sugar (in people with type 2 diabetes), upset stomach, heartburn, burping, gas, bloating, nausea, vomiting, stomach pain, loss of appetite, diarrhea, constipation, stomach flu symptoms, headache, dizziness, and tiredness
Liraglutide, brand name Saxenda, which comes in multiple doses and is administered once a day as an injection, Semaglutide, brand name Wegovy, also an injection also but administered weekly
US$ 29.72
.jpg?size=large)
US$ 29.44
US$ 22.47
US$ 28.90
US$ 21.61
US$ 27.82
US$ 29.83
US$ 29.76
